Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 14, 2009; 15(30): 3713-3724
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713
Published online Aug 14, 2009. doi: 10.3748/wjg.15.3713
Figure 2 Results of virologic response in different studies.
PRESCO study 33% and 84%, respectively, at weeks 4 and 12 for GT-1 infections; APRICOT study 13% and 34%; PISG study 31% and 71% respectively. Similar figures for GT-2 and -3 infections were 47% and 92%, 37% and 72%, 84% and 96%, respectively.
- Citation: Singal AK, Anand BS. Management of hepatitis C virus infection in HIV/HCV co-infected patients: Clinical review. World J Gastroenterol 2009; 15(30): 3713-3724
- URL: https://www.wjgnet.com/1007-9327/full/v15/i30/3713.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3713